[artículo] 
inThe Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.6 (Junio) . - pp. 622-627

Título :	Participants with schizophrenia retain the information necessary for informed consent during clinical trials
Tipo de documento:	texto impreso
Autores:	Bernard A. Fischer, Autor ; Robert P. McMahon, Autor ; Walter A. Meyer, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 622-627
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Consentimiento informado, Competencia mental, Psicología esquizofrénica, Conceptos erróneos terapéuticos
Resumen:	Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable participation in clinical trials. This study monitored retention of study-related knowledge-including assessment of therapeutic misconception-in people with stable, DSM-IV schizophrenia during participation in placebo-controlled clinical trials of adjunctive agents.
Link:	./index.php?lvl=notice_display&id=27862

[artículo] Participants with schizophrenia retain the information necessary for informed consent during clinical trials [texto impreso] / Bernard A. Fischer, Autor ; Robert P. McMahon, Autor ; Walter A. Meyer, Autor . - 2022 . - pp. 622-627.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.6 (Junio) . - pp. 622-627

Palabras clave:	Consentimiento informado, Competencia mental, Psicología esquizofrénica, Conceptos erróneos terapéuticos
Resumen:	Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable participation in clinical trials. This study monitored retention of study-related knowledge-including assessment of therapeutic misconception-in people with stable, DSM-IV schizophrenia during participation in placebo-controlled clinical trials of adjunctive agents.
Link:	./index.php?lvl=notice_display&id=27862